The increasing prevalence of peripheral artery disease is contributing significantly to the global peripheral vascular interventions market growth says Fortune Business Insights in a report, titled “Peripheral Vascular Interventions Market Size, Share and Global Trend
Rising cases of obesity and high cholesterol are factors driving the global peripheral vascular interventions market.
Top Key Players Covered:
Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the global Peripheral Vascular Interventions market. Some of the companies operating the global Peripheral Vascular Interventions market are;
- Edwards Lifesciences Corporation
- Cardinal Health
- TERUMO CORPORATION
- R. Bard, Inc.
- Braun Melsungen AG
- Boston Scientific Corporation
- AngioScore Inc.
- Biotronik, Inc.
- Biosensors International Group, Ltd.
By Procedure Type
By End User
- Ambulatory Surgery Centres
Biotronik’s New Treatment Tool Will Encourage Market Growth
Biotronik, a privately held multinational biomedical technology company, announced Carnelian support catheter. The new treatment tool is designed to improve the access for treating of tortuous and highly calcified lesions. The launch of the carnelian tool is expected to promote the peripheral vascular disease nursing interventions owing to the Japanese crossing technique that enables the treatment of very complex lesions.
Minimal Procedural Time in Peripheral Interventions Will Fuel Demand
Smoking, high cholesterol, obesity, and diabetes are some of the factors responsible for peripheral artery disease. According to the National Heart, Lung and Blood Institute, an estimated 5.0% of population over 50 years suffer due to peripheral artery disease each year in the U.S. Enhanced safety, minimal hospital stays, faster recovery, and minimal procedural time are some factors fueling demand for peripheral vascular disease nursing interventions and thus contributing to peripheral vascular interventions shares. According to the Centers for Disease Control and Prevention, an estimated 8.5 million people in the U.S. are affected by peripheral artery disease, also 10.0-12.0% of the population is 50 years old.
Increasing Cases of Peripheral Artery Disease in The US Will Boost Growth
Geographically, the global peripheral vascular interventions market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America led the global peripheral vascular interventions market in 2017 and is expected to dominate in the forthcoming year owing to rising prevalence of peripheral artery diseases and growing geriatric population. Increasing risk factors for peripheral artery diseases such as obesity and diabetes are fueling demand for peripheral vascular interventions in the region.
More Trending Topics From Fortune Business [email protected]
Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.